Ubs Group Ag Akouos, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.16 - $9.08 $10,645 - $23,235	-2,559 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.65 - $11.38 $13,770 - $20,484	1,800 Added 237.15%	2,559 $22,000
Q3 2021 Nov 15, 2021	SELL	$9.93 - $13.59 $1,350 - $1,848	-136 Reduced 15.2%	759 $9,000
Q2 2021 Aug 13, 2021	BUY	$11.87 - $15.96 $1,768 - $2,378	149 Added 19.97%	895 $11,000
Q1 2021 May 12, 2021	SELL	$13.87 - $21.04 $114,912 - $174,316	-8,285 Reduced 91.74%	746 $10,000
Q4 2020 Feb 11, 2021	BUY	$17.03 - $22.45 $153,797 - $202,745	9,031 New	9,031 $179,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.